Acadian Asset Management’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38K Sell
27,597
-1,776,520
-98% -$2.7M ﹤0.01% 1885
2025
Q4
$3.58M Sell
1,804,117
-49,305
-3% -$75.8K 0.01% 737
2025
Q3
$3.01M Buy
+1,853,422
New +$3.62M 0.01% 781
2025
Q1
Sell
-56,273
Closed -$131K 1603
2024
Q4
$131K Buy
+56,273
New +$190K ﹤0.01% 1321
2023
Q2
Sell
-12,192
Closed -$22K 1722
2023
Q1
$22K Sell
12,192
-9,833
-45% -$19.2K ﹤0.01% 1641
2022
Q4
$40K Buy
+22,025
New +$55.7K ﹤0.01% 1609
2022
Q3
Sell
-34,888
Closed -$98K 1668
2022
Q2
$98K Buy
+34,888
New +$106K ﹤0.01% 1359
2021
Q4
Sell
-31,289
Closed -$204K 1667
2021
Q3
$204K Buy
+31,289
New +$198K ﹤0.01% 1288
2020
Q4
Sell
-2,062
Closed -$24K 2195
2020
Q3
$24K Sell
2,062
-2,233
-52% -$32.4K ﹤0.01% 2036
2020
Q2
$69K Buy
+4,295
New +$47.6K ﹤0.01% 1819

Other funds holding AUTL